Wolf Theiss advised Synthesis Capital on the deal. Synthesis Capital executed an investment in Arkeon Biotechnologies, a startup which uses an ancient microbe to turn CO2...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here